Reading this on a mobile device? Try our optimized mobile version here:

November 20, 2012
Sign upForwardArchiveAdvertise
News for nuclear medicine and molecular imaging professionals
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at

  Top Story 
  • Company commences Technegas trial in U.S.
    Cyclopharm has enrolled the first patient in a U.S. clinical trial involving its Technegas product, a gas inhaled by patients before imaging to improve detection of blood clots in the lungs. The multi-center study will eventually involve 750 patients and is expected to be completed in 18 months. (Australia) (11/19) LinkedInFacebookTwitterEmail this Story
Nuclear Medicine Series
CriticalPoint is offering updated education and a way to earn ASRT
Cat A or ACPE CE
. 11 unique courses address fundamental skills while meeting the needs of Nuclear Pharmacists, Technicians and Nuclear Medicine Technologists. Register @ - limited # get FREE TRAINING using code: NUCEDU
  Clinical News & Research 
  • Researchers to share 3 PEM studies at upcoming meeting
    Researchers are set to present three studies on positron emission mammography at an upcoming radiology meeting. One study, considered a pilot, showed PEM has a 98% specificity in diagnosing the metastasis of breast cancer to axillary lymph nodes. The method may prevent the unnecessary use of sentinel lymph node procedures while improving the detection of metastases, researchers said. MarketWatch/Marketwire/News release (11/19) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  News from the Field 
  Health Policy 
  • FDA continues to wrestle with personnel challenges, report says
    The FDA has made strides in strengthening its scientific workforce since 2007 through efforts such as enhanced training for medical device reviewers, but it still faces management and staffing challenges, says a Partnership for Public Service report set to be released today. The report urges the FDA to devise targeted recruitment programs, among other recommendations. The Washington Post (11/19) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • Epocrates unveils iPad drug data app
    Epocrates recently unveiled an iPad version of its iPhone drug data application that enables doctors to effectively search the firm's drug database, examine drug interactions and compare different drugs at the same time. Future versions of the app might be capable of backing customized dashboards for users in various health specialties, said Epocrates CEO Andy Hurd. (11/15) LinkedInFacebookTwitterEmail this Story
  From SNMMI 
  • Submit an abstract for the SNMMI 2013 Annual Meeting
    Abstracts are currently being accepted for the SNMMI 2013 Annual Meeting, June 8-12, 2013, in Vancouver. Submit an abstract on the following topics: neurosciences, general clinical specialties, molecular targeting probes -- radioactive and nonradioactive, instrumentation and data analysis, oncology: basic, translational and therapy, and oncology: clinical diagnosis. Submission deadline is Jan. 4, 2013. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

A good man with a good conscience doesn't walk so fast."
--Georg Büchner,
German writer

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Account Director:   Meryl Harold   (202) 407-7828
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.®  Legal Information